Human iPSC-derived Vascularized Ventricular Cardiac Organoid
These advanced organoids incorporate both ventricular cardiomyocytes and vascular endothelial networks, providing a more physiologically relevant 3D cardiac tissue model. They exhibit improved nutrient diffusion, chamber-specific electrophysiology, and long-term functionality.
Benefits
- Combines ventricular cardiac and vascular endothelial compartments
- Enhanced longevity and maturation in culture
- Ideal for drug safety testing, regenerative medicine, and disease modeling
Product Specifications
|
Feature |
Detail |
|---|---|
|
Identity Markers |
Ventricular markers (MLC2v, TNNT2) + endothelial markers (CD31, VE-Cadherin) |
|
Quantities |
≥ 1 × 10⁶ cells per vascularized organoid |
|
Quality Control |
Electrophysiology, contractility, vascular perfusion assays, mycoplasma testing |
|
Format |
Cryopreserved vascularized 3D organoids |
|
Donor & Reprogramming |
Healthy donor; Sendai virus reprogramming |
|
Shipping / Storage |
Dry shipper at -180°C to -135°C |
|
Supplied with |
Specialized culture medium and user instructions |
Explore Vascularized Ventricular Cardiac Organoid
Advance your gastrointestinal research with our iPSC-derived gut organoids that recreate key structural and functional features of the human intestine. These organoids are ideal for disease modeling, drug absorption studies, microbiome interaction research, and toxicity screening. Check the product details to see how they can support and accelerate your GI biology workflows.